A Popular Joint Pain Supplement May Actually Speed Up Dementia Progression - Health: Trusted and Empathetic Health and Wellness Information
A University of Florida study suggests the joint supplement glucosamine may accelerate the progression from mild cognitive impairment to Alzheimer's disease. Researchers found a 25% higher likelihood of developing dementia among users. The study also noted a 25% higher mortality risk for dementia patients using the supplement.
What changed
New research from the University of Florida identifies a potential link between glucosamine use and accelerated cognitive decline.
Live updates
-
Glucosamine Linked to Faster Alzheimer's Progression
confidence 90%A University of Florida study suggests the joint supplement glucosamine may accelerate the progression from mild cognitive impairment to Alzheimer's disease. Researchers found a 25% higher likelihood of developing dementia among users. The study also noted a 25% higher mortality risk for dementia patients using the supplement.
What's confirmed:
- A study published in Nature Metabolism on June 9, 2026, links glucosamine use to 25% faster progression from mild cognitive impairment to Alzheimer's disease.
- Glucosamine users showed a 25% higher likelihood of developing dementia.
- Researchers used artificial intelligence to analyze UF Health records from 2012 to 2024.
- In the study, 1,896 patients with Alzheimer's disease or related dementias and 2,750 patients with mild cognitive impairment reported taking glucosamine.
- Hyperglycosylation is a metabolic driver of Alzheimer's disease.
Still unconfirmed:
- Glucosamine use is linked to a 25% higher mortality risk among dementia patients.
- Glucosamine may worsen Alzheimer's by fueling abnormal brain glycosylation.
- The supplement may increase overall mortality.